Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: ease: the issue over ownership of MMP "Work Product"

was discussed in legal filings or is detailed in the Commercial Agreement. My recollection of the bottom line take away was that TPL owns the "Work Product"; and that would include Reverse Engineering and identification of infringers involved in the licensing and prosecution effort.

The importance of this issue and the leverage it has created cannot be overstated.

Share
New Message
Please login to post a reply